Why Teladoc Health Has a Wider Moat Than You Might Think
Investors have soured on Teladoc Health (NYSE: TDOC) stock, as evidenced by its 68% decline from earlier this year. The market appears to believe that the company lacks any competitive advantage to thrive in a world that's looking to move beyond the pandemic. However, in this video from Motley Fool Backstage Pass, recorded on Nov. 29, contributor Jason Hall lays out for fellow contributors Matt Frankel and Jon Quast how Teladoc has a lot of patient data, among other things, which gives its business a wider moat than you might think.
Source Fool.com
